Literature DB >> 8698503

Molecular basis of size and antigenic variation of a Mycoplasma hominis adhesin encoded by divergent vaa genes.

Q Zhang1, K S Wise.   

Abstract

The molecular basis for the size and antigenic diversity of the variable adherence-associated (Vaa) antigen, a major surface protein and a putative adhesin (of Mycoplasma hominis, is described. Size-variant alleles of the single-copy vaa gene encode abundant surface lipoproteins containing one to four nearly identical, tandem repetitive units of 121 amino acids in the central region of the mature Vaa product. Gain or loss of central repeats in vaa genes gives rise to distinct size-variant Vaa antigens in clonal populations of this organism. The N-terminal and repeat regions of Vaa contain highly conserved sequences, while the C-terminal region, implicated as the adherence-mediating module, is highly variable and divergent among different strains of this pathogen. Sequence variation in this region may underlie the strain-dependent binding of some monoclonal antibodies to Vaa products. The Vaa antigen is expressed in vivo during chronic, active arthritis associated with M. hominis infection and is highly immunogenic in the human host. Size variation and C-terminal antigenic divergence of Vaa could affect the adherence of M. hominis and evasion of antibody-mediated immunity, thereby contributing to the organism's adaptive capability in the human host. Variation in vaa genes reveals a distinct pattern of mutations generating mycoplasma surface variation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8698503      PMCID: PMC174134          DOI: 10.1128/iai.64.7.2737-2744.1996

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  46 in total

1.  Evolution of repeated DNA sequences by unequal crossover.

Authors:  G P Smith
Journal:  Science       Date:  1976-02-13       Impact factor: 47.728

2.  Mycoplasma hyorhinis vlp gene transcription: critical role in phase variation and expression of surface lipoproteins.

Authors:  C Citti; K S Wise
Journal:  Mol Microbiol       Date:  1995-11       Impact factor: 3.501

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Division of mycoplasmas into subgroups.

Authors:  H C Neimark
Journal:  J Gen Microbiol       Date:  1970-10

Review 5.  Lipoproteins of gram-positive bacteria.

Authors:  I C Sutcliffe; R R Russell
Journal:  J Bacteriol       Date:  1995-03       Impact factor: 3.490

6.  A comprehensive set of sequence analysis programs for the VAX.

Authors:  J Devereux; P Haeberli; O Smithies
Journal:  Nucleic Acids Res       Date:  1984-01-11       Impact factor: 16.971

7.  A simple method for displaying the hydropathic character of a protein.

Authors:  J Kyte; R F Doolittle
Journal:  J Mol Biol       Date:  1982-05-05       Impact factor: 5.469

8.  Mycoplasma hyorhinis GDL surface protein antigen p120 defined by monoclonal antibody.

Authors:  K S Wise; R K Watson
Journal:  Infect Immun       Date:  1983-09       Impact factor: 3.441

9.  Construction of an ordered genomic library of Mycoplasma genitalium.

Authors:  T S Lucier; P Q Hu; S N Peterson; X Y Song; L Miller; K Heitzman; K F Bott; C A Hutchison; P C Hu
Journal:  Gene       Date:  1994-12-02       Impact factor: 3.688

10.  UGA is read as tryptophan in Mycoplasma capricolum.

Authors:  F Yamao; A Muto; Y Kawauchi; M Iwami; S Iwagami; Y Azumi; S Osawa
Journal:  Proc Natl Acad Sci U S A       Date:  1985-04       Impact factor: 11.205

View more
  38 in total

1.  The vsp locus of Mycoplasma bovis: gene organization and structural features.

Authors:  I Lysnyansky; K Sachse; R Rosenbusch; S Levisohn; D Yogev
Journal:  J Bacteriol       Date:  1999-09       Impact factor: 3.490

2.  Gene rearrangements in the vsa locus of Mycoplasma pulmonis.

Authors:  X Shen; J Gumulak; H Yu; C T French; N Zou; K Dybvig
Journal:  J Bacteriol       Date:  2000-05       Impact factor: 3.490

3.  P48 major surface antigen of Mycoplasma agalactiae is homologous to a malp product of Mycoplasma fermentans and belongs to a selected family of bacterial lipoproteins.

Authors:  S Rosati; S Pozzi; P Robino; B Montinaro; A Conti; M Fadda; M Pittau
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

4.  Characterization of a multigene family undergoing high-frequency DNA rearrangements and coding for abundant variable surface proteins in Mycoplasma agalactiae.

Authors:  M D Glew; L Papazisi; F Poumarat; D Bergonier; R Rosengarten; C Citti
Journal:  Infect Immun       Date:  2000-08       Impact factor: 3.441

5.  Molecular design of Mycoplasma hominis Vaa adhesin.

Authors:  T Boesen; N U Fedosova; M Kjeldgaard; S Birkelund; G Christiansen
Journal:  Protein Sci       Date:  2001-12       Impact factor: 6.725

6.  Mycoplasma pneumoniae P1 type 1- and type 2-specific sequences within the P1 cytadhesin gene of individual strains.

Authors:  J W Dorigo-Zetsma; B Wilbrink; J Dankert; S A Zaat
Journal:  Infect Immun       Date:  2001-09       Impact factor: 3.441

7.  Coupled phase-variable expression and epitope masking of selective surface lipoproteins increase surface phenotypic diversity in Mycoplasma hominis.

Authors:  Q Zhang; K S Wise
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

8.  Mapping antigenic sites of an immunodominant surface lipoprotein of Mycoplasma agalactiae, AvgC, with the use of synthetic peptides.

Authors:  Antonella Santona; Franco Carta; Peppinetta Fraghí; Franco Turrini
Journal:  Infect Immun       Date:  2002-01       Impact factor: 3.441

9.  Surface diversity in Mycoplasma agalactiae is driven by site-specific DNA inversions within the vpma multigene locus.

Authors:  Michelle D Glew; Marc Marenda; Renate Rosengarten; Christine Citti
Journal:  J Bacteriol       Date:  2002-11       Impact factor: 3.490

10.  Variable surface protein Vmm of Mycoplasma mycoides subsp. mycoides small colony type.

Authors:  Anja Persson; Karin Jacobsson; Lars Frykberg; Karl-Erik Johansson; François Poumarat
Journal:  J Bacteriol       Date:  2002-07       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.